Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Peru has been on the rise in recent years due to various factors.
Customer preferences: Peruvian customers have become more health-conscious and aware of the importance of preventive healthcare measures. This has led to an increased demand for vaccines, as people seek to protect themselves and their families from preventable diseases. Additionally, the government has been actively promoting vaccination programs, which has further fueled demand among the population.
Trends in the market: The vaccines market in Peru has seen a shift towards more advanced and specialized vaccines, such as those for HPV and pneumococcal disease. This trend is driven by the increasing prevalence of these diseases in the country, as well as the growing awareness of the effectiveness of these vaccines in preventing them. Moreover, the market has witnessed a rise in the number of private clinics offering vaccines, as people seek more convenient and personalized healthcare services.
Local special circumstances: One of the unique challenges facing the vaccines market in Peru is the country's diverse geography and population. Peru has a large rural population, which can be difficult to reach with vaccination programs due to the lack of infrastructure and healthcare facilities in these areas. Additionally, there are cultural and linguistic barriers that can make it harder to communicate the importance of vaccines to certain groups.
Underlying macroeconomic factors: Peru's growing economy has contributed to the expansion of the vaccines market, as people have more disposable income to spend on healthcare. Furthermore, the government has been investing in healthcare infrastructure and programs, which has helped to improve access to vaccines across the country. However, the market is also affected by external factors such as global vaccine shortages and fluctuations in exchange rates, which can impact pricing and availability.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
